logo
  • Home
  • News
Menu

Why Ardelyx Stock Is Getting Crushed Today

Home / Stock Analysis / Why Ardelyx Stock Is Getting Crushed Today
Article feature image

Why Ardelyx Stock Is Getting Crushed Today

20 Jul Stock Analysis

What happened
Shares of the small-cap biotech Ardelyx(NASDAQ:ARDX) fell by a whopping 73.2% in pre-market action Tuesday morning. The drugmaker’s stock is tanking today in response to a July 13 letter from the U.S. Food and Drug Administration regarding…

Click here to view the original article.

Tags:
Global, Motley Fool
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

fermi-inc-nasdaq-frmi-stock-news-on-dec-24-2025-new-52-week-low-project-matador-tenant-fallout-and-a.jpeg
+

New 52-Week Low, Project Matador Tenant Fallout, and Analyst Price Targets

24 Dec Stock Analysis
johnson-johnson-stock-today-jnj-holds-near-207-on-dec-24-2025-as-talc-verdict-drug-price-pressure-an.jpeg
+

JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

24 Dec Stock Analysis

recent post

  • Spain-new-crypto-regulations-in-2026-1000x600.webp.webp

    Spain to expose every crypto transaction:

    Dec 24 2025
  • press-release-1766569038554-0-1200x800.png

    AI Crypto Coins December 2025: BlackRock

    Dec 24 2025
  • C7AKIHSK4FHDRC547KUQXY3IN4.jpg

    Gunman arrested for nearly $1M crypto,

    Dec 24 2025
  • press-release-1766568822072-0.png

    Best Crypto Presales for 2026 Include

    Dec 24 2025
  • fermi-inc-nasdaq-frmi-stock-news-on-dec-24-2025-new-52-week-low-project-matador-tenant-fallout-and-a.jpeg

    New 52-Week Low, Project Matador Tenant

    Dec 24 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.